| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/05/2000 | EP0866874B1 Process for the preparation of materials with a high content of isomers of conjugated linoleic acid |
| 07/05/2000 | EP0831923A4 Separation of active complexes |
| 07/05/2000 | EP0752877B1 Stabilized composition for oral administration of peptides |
| 07/05/2000 | EP0528891B1 Method for increasing blood-brain barrier permeability |
| 07/05/2000 | CN1259152A Polymers with thiol terminal function |
| 07/05/2000 | CN1259134A Novel class of nucleic acid cationic transfecting agents |
| 07/05/2000 | CN1259053A Medicinal composition |
| 07/05/2000 | CN1259051A Stabilized human papillomavirus formulations |
| 07/05/2000 | CN1259050A Composition comprising 5-[4-(2-(N-methyl-N-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione |
| 07/05/2000 | CN1259048A Semisolid pharmaceutical formulation containing dexketoprofen trometamol |
| 07/05/2000 | CN1259045A Method for oral delivery of proteins |
| 07/05/2000 | CN1258503A Vitamine preparation |
| 07/05/2000 | CN1054041C Process for preparing stabilized ascorbic acid composition |
| 07/05/2000 | CN1054040C Preparation of ion exchange resins loaded with quinolonecarboxylic acid derivatives |
| 07/04/2000 | US6084110 Infusion preparation composed of a vitamin c preparation blended with an electrolyte infusion solution containing a magnesium stabilizer, e.g., magnesium acetate, lactate, chloride, sulfate; storage stability; injections; nutrients |
| 07/04/2000 | US6084092 β(1-3)-glucan diagnostic assays |
| 07/04/2000 | US6084074 Stabilized aqueous liquid preparations of blood coagulation factor XIII |
| 07/04/2000 | US6083996 Topical compositions for NSAI drug delivery |
| 07/04/2000 | US6083962 Agonist-anatagonist combination to reduce the use of nicotine and other drugs |
| 07/04/2000 | US6083930 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 07/04/2000 | US6083916 Pharmaceutical product for application to uterus mucosa |
| 07/04/2000 | US6083909 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers |
| 07/04/2000 | US6083741 Nucleotide sequences linked to regulatory sequences which code a peptide or protein; for efficient transfer of nuucleotide sequences into cells; for gene therapy |
| 07/04/2000 | US6083532 Tablets for sustained release of drugs and gelling polymer |
| 07/04/2000 | US6083531 Fast disintegrating oral dosage form |
| 07/04/2000 | US6083523 Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products |
| 07/04/2000 | US6083521 Drugs and polyethylene carbonates |
| 07/04/2000 | US6083518 Bactericide cleaning compounds with surfactants |
| 07/04/2000 | US6083502 Methods for detecting the antigen and its expression level as an indication of the presence of tumor cells |
| 07/04/2000 | US6083495 Method of making phosphate-binding polymers for oral administration |
| 07/04/2000 | US6083478 Consists of a cytotoxic radionuclide and a homodimer comprising two heavy chains encoded by the expression vector designated cd4-igg2-pcdna1 (atcc no. 40952) |
| 07/04/2000 | US6083477 Useful therapeutic reagents for treating leukemias and lymphomas;conjugate of a non-immunogenic rnase or a therapeutic radionuclide that is an alpha-emitter or a beta-emitter and a cell-specific cytokine |
| 07/04/2000 | US6083421 Film coating composition for whitening teeth |
| 07/04/2000 | US6083190 Device for enhanced electrotransport agent delivery |
| 07/04/2000 | CA2169356C Phosphate-binding polymers for oral administration |
| 06/29/2000 | WO2000037664A1 Method for preparing suspension of stable posiplexes |
| 06/29/2000 | WO2000037659A1 Non-viral transfection vector |
| 06/29/2000 | WO2000037138A1 Thin polymer film drug reservoirs |
| 06/29/2000 | WO2000037124A1 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 06/29/2000 | WO2000037112A1 Pharmaceutical compositions comprising immortalised endothelial cells |
| 06/29/2000 | WO2000037109A2 Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions |
| 06/29/2000 | WO2000037108A1 Oil-in-water emulsion exhibiting a protective action against damages to human organs resulting from peroxidation, and the production and use thereof |
| 06/29/2000 | WO2000037106A1 Oral vaccine against diarrhea |
| 06/29/2000 | WO2000037103A2 Compounds for intracellular delivery of therapeutic moieties to nerve cells |
| 06/29/2000 | WO2000037099A2 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor |
| 06/29/2000 | WO2000037098A1 Shelf-stable formulation of glucagon-like peptide-1 |
| 06/29/2000 | WO2000037081A1 Novel formulation |
| 06/29/2000 | WO2000037080A1 Ophthalmic compositions comprising pheniramine and povidone |
| 06/29/2000 | WO2000037069A1 New utilization of alpha-hidroxy-propionic acid in medicine |
| 06/29/2000 | WO2000037062A2 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents |
| 06/29/2000 | WO2000037057A2 Novel formulations comprising lipid-regulating agents |
| 06/29/2000 | WO2000037055A1 Controlled release formulation of divalproex sodium |
| 06/29/2000 | WO2000037053A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 06/29/2000 | WO2000037052A1 Pulmonary drug delivery |
| 06/29/2000 | WO2000037051A1 Aerosol formulations for buccal and pulmonary application |
| 06/29/2000 | WO2000037050A1 Water-insoluble drug delivery system |
| 06/29/2000 | WO2000037047A1 Composition set and kit for use in intraocular surgery |
| 06/29/2000 | WO2000037046A1 Therapeutic delivery using compounds self-assembled into high axial ratio microstructures |
| 06/29/2000 | WO2000037043A1 Foaming antacid suspension tablets |
| 06/29/2000 | WO2000037027A1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system |
| 06/29/2000 | WO2000036983A1 Pegylated photosensitizers for abnormal tissue treatment |
| 06/29/2000 | WO2000036918A1 Methods and compositions for treatment of cell proliferative disorders |
| 06/29/2000 | WO2000024437A8 Textured and porous silicone rubber |
| 06/29/2000 | WO2000013687A3 Sustained release ranolazine formulations |
| 06/29/2000 | WO2000009073A3 Blood-brain barrier therapeutics |
| 06/29/2000 | WO1999064065A3 Tumour therapy and imaging |
| 06/29/2000 | WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 06/29/2000 | WO1999055386A3 Stimulus sensitive gel with radioisotope and methods of making |
| 06/29/2000 | WO1999049019A3 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| 06/29/2000 | DE19935305A1 Feste, stabile Brenztraubensäure/Kohlenhydrat(-Derivat)- Aggregate bzw. deren Hydrate und Verfahren zu ihrer Herstellung Solid, stable pyruvic acid / carbohydrate (derivative) - Genset or their hydrates and methods for their preparation |
| 06/29/2000 | DE19859910A1 Cyclosporin-Lösung Cyclosporin solution |
| 06/29/2000 | DE19859499A1 Stable ginger extract preparations useful for treating dyspepsia or travel sickness, contain oil, triglyceride or fatty acid or alcohol as stabilizing auxiliary |
| 06/29/2000 | DE19859231A1 Schäumende Antacida-Suspensionstabletten Foaming antacid suspension tablets |
| 06/29/2000 | DE19859045A1 Emulsion vom Typ Öl in Wasser mit Schutzwirkung gegen Peroxidationsschäden an menschlichen Organen, deren Herstellung und Verwendung Emulsion of oil in water with a protective effect against peroxidation of human organs, their preparation and use |
| 06/29/2000 | CA2356454A1 Compounds for intracellular delivery of therapeutic moieties to nerve cells |
| 06/29/2000 | CA2356366A1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system |
| 06/29/2000 | CA2355879A1 Pharmaceutical compositions comprising immortalised endothelial cells |
| 06/29/2000 | CA2355820A1 Novel formulations comprising lipid-regulating agents |
| 06/29/2000 | CA2355696A1 Therapeutic delivery using compounds self-assembled into high axial ratio microstructures |
| 06/29/2000 | CA2355627A1 Foaming antacid suspension tablets |
| 06/29/2000 | CA2355148A1 Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions |
| 06/29/2000 | CA2353848A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 06/29/2000 | CA2353790A1 Non-viral transfection vector |
| 06/29/2000 | CA2352535A1 Method for preparing suspension of stable posiplexes |
| 06/29/2000 | CA2352309A1 Oral vaccine against diarrhea |
| 06/29/2000 | CA2293177A1 Nanoemulsion based on ethoxylate fatty ethers or ethoxylate fatty esters, and its utilizations in cosmetics, dermatology and/or ophthalmology |
| 06/28/2000 | EP1013777A1 Powdered dextrose and method for preparing same |
| 06/28/2000 | EP1013772A1 Method for preparing suspension of stable posiplexes |
| 06/28/2000 | EP1013770A1 Non-viral transfection vector |
| 06/28/2000 | EP1013664A1 Antigenic determinants for drug-specific T lymphocytes from drug-allergic patients |
| 06/28/2000 | EP1013287A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/28/2000 | EP1013279A1 Method for producing a support and storage material for plants and their active ingredients, production of liquids from this material and use of said liquids as therapeutic, cosmetic or cleansing agents |
| 06/28/2000 | EP1013274A2 Composition comprising amoxycillin and clavulanic acid |
| 06/28/2000 | EP1013270A2 Controlled release growth hormone containing microspheres |
| 06/28/2000 | EP1013178A1 Petroselinic acid and its use in food, fat compositions containing petroselinic acid |
| 06/28/2000 | EP1013175A1 Sugarfree candied product |
| 06/28/2000 | EP1012603A1 Functional fragments of hiv-1 vpr protein and methods of using the same |
| 06/28/2000 | EP1012563A1 Breath test for detection of drug metabolism |
| 06/28/2000 | EP1012331A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 06/28/2000 | EP1012320A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |